Levy Richard N 4
4 · UNIGENE LABORATORIES INC · Filed Dec 22, 2010
Insider Transaction Report
Form 4
Levy Richard N
Director
Transactions
- Purchase
Common Stock
2010-12-22$0.74/sh+50,000$37,000→ 9,147,464 total(indirect: See Footnote) - Purchase
Common Stock
2010-12-20$0.75/sh+50,000$37,500→ 9,047,464 total(indirect: See Footnote) - Purchase
Common Stock
2010-12-21$0.75/sh+50,000$37,500→ 9,097,464 total(indirect: See Footnote)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions (all on December 20, 2010) at prices ranging from $0.73 to $0.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]All of the reported securities are beneficially owned directly by Victory Park Credit Opportunities Master Fund, Ltd. (the "Fund") and indirectly by (i) Victory Park Capital Advisors, LLC ("Advisors") as the investment manager for the Fund, (ii) Jacob Capital, L.L.C. ("Jacob"), as the manager of Advisors, and (iii) Richard Levy, as the sole member of Jacob. Each of Advisors, Jacob and Mr. Levy disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions (all on December 21, 2010) at prices ranging from $0.72 to $0.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions (all on December 22, 2010) at prices ranging from $0.72 to $0.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.